Matthew Stanton's Insider Trades & SAST Disclosures
Matthew Stanton's most recent trade in Generation Bio Co was a trade of 1,674 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew Stanton.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 1,674 | 15,059 | - | - | Restricted Stock Units | |
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 1,674 | 247,811 | - | - | Common Stock | |
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. | 15 Oct 2024 | 492 | 247,319 | - | 2.4 | 1,191 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 1,674 | 246,629 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 1,674 | 16,733 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 15 Jul 2024 | 492 | 246,137 | - | 2.9 | 1,442 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 1,674 | 18,407 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 1,674 | 245,447 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Apr 2024 | 492 | 244,955 | - | 3.7 | 1,820 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 7,437 | 0 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 7,437 | 241,976 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 6,694 | 246,093 | - | - | Common Stock | |
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 6,694 | 20,081 | - | - | Restricted Stock Units | |
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 2,577 | 239,399 | - | 1.9 | 4,922 | Common Stock |
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 2,320 | 243,773 | - | 1.9 | 4,431 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 160,650 | 160,650 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 76,310 | 76,310 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 7,437 | 14,874 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 7,437 | 231,468 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 15 Jul 2023 | 2,183 | 229,285 | - | 5.1 | 11,090 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 7,437 | 226,214 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 7,437 | 22,311 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 15 Apr 2023 | 2,183 | 224,031 | - | 4.5 | 9,824 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 53,550 | 53,550 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,775 | 26,775 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 7,438 | 29,748 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 7,438 | 221,355 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. | 15 Jan 2023 | 2,578 | 218,777 | - | 5.1 | 13,148 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 7,438 | 37,186 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 7,438 | 216,101 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 15 Oct 2022 | 2,184 | 213,917 | - | 5.6 | 12,252 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,876 | 213,030 | - | - | Common Stock | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,876 | 44,624 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 15 Jul 2022 | 4,367 | 208,663 | - | 7.2 | 31,355 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 119,000 | 119,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 59,500 | 59,500 | - | - | Restricted Stock Units | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 14 Sep 2021 | 4,500 | 198,154 | - | 28.1 | 126,315 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2021 | 4,500 | 85,577 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 14 Sep 2021 | 4,500 | 202,654 | - | 4.6 | 20,655 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 3,000 | 90,077 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 10 Sep 2021 | 3,000 | 201,154 | - | 4.6 | 13,770 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 25.69 per share. | 10 Sep 2021 | 2,200 | 198,954 | - | 25.7 | 56,518 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 26.74 per share. | 10 Sep 2021 | 800 | 198,154 | - | 26.7 | 21,392 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 23 Aug 2021 | 1,500 | 198,154 | - | 25.0 | 37,560 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 1,500 | 93,077 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 23 Aug 2021 | 1,500 | 199,654 | - | 4.6 | 6,885 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 1,500 | 94,577 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 10 Aug 2021 | 1,500 | 199,654 | - | 4.6 | 6,885 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 22.18 per share. | 10 Aug 2021 | 1,000 | 198,654 | - | 22.2 | 22,180 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 23.36 per share. | 10 Aug 2021 | 400 | 198,254 | - | 23.4 | 9,344 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 24.19 per share. | 10 Aug 2021 | 100 | 198,154 | - | 24.2 | 2,419 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 3,000 | 96,077 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 12 Jul 2021 | 3,000 | 201,154 | - | 4.6 | 13,770 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 25.51 per share. | 12 Jul 2021 | 1,700 | 198,154 | - | 25.5 | 43,367 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 24.40 per share. | 12 Jul 2021 | 1,300 | 199,854 | - | 24.4 | 31,720 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 15 Jun 2021 | 1,500 | 199,654 | - | 4.6 | 6,885 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 1,500 | 99,077 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 15 Jun 2021 | 1,500 | 198,154 | - | 28.1 | 42,120 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 10 Jun 2021 | 6,000 | 204,154 | - | 4.6 | 27,540 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 6,000 | 100,577 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.23 per share. | 10 Jun 2021 | 6,000 | 198,154 | - | 27.2 | 163,380 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 34.05 per share. | 27 May 2021 | 1,500 | 198,154 | - | 34.1 | 51,075 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,500 | 106,577 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 27 May 2021 | 1,500 | 199,654 | - | 4.6 | 6,885 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 10 May 2021 | 8,600 | 206,754 | - | 0.6 | 5,160 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 8,600 | 16,594 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 30.37 per share. | 10 May 2021 | 6,200 | 200,554 | - | 30.4 | 188,294 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 10 May 2021 | 2,100 | 198,454 | - | 31.0 | 65,163 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 10 May 2021 | 400 | 198,154 | - | 31.1 | 12,420 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 32.19 per share. | 10 May 2021 | 300 | 198,154 | - | 32.2 | 9,657 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 228 | 108,077 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 10 May 2021 | 228 | 198,554 | - | 4.6 | 1,047 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 172 | 16,422 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 10 May 2021 | 172 | 198,326 | - | 0.6 | 103 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 21 Apr 2021 | 1,500 | 199,654 | - | 0.6 | 900 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 34.03 per share. | 21 Apr 2021 | 1,500 | 198,154 | - | 34.0 | 51,045 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 1,500 | 26,694 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 1,500 | 25,194 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 21 Apr 2021 | 1,500 | 199,654 | - | 0.6 | 900 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 31.07 per share. | 21 Apr 2021 | 1,500 | 198,154 | - | 31.1 | 46,605 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 1,500 | 28,194 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 16 Apr 2021 | 1,500 | 199,654 | - | 0.6 | 900 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 16 Apr 2021 | 1,500 | 198,154 | - | 28.0 | 42,045 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 6,000 | 29,694 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 12 Apr 2021 | 6,000 | 204,154 | - | 0.6 | 3,600 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 26.12 per share. | 12 Apr 2021 | 4,900 | 199,254 | - | 26.1 | 127,988 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 26.78 per share. | 12 Apr 2021 | 1,100 | 198,154 | - | 26.8 | 29,458 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 10,500 | 35,694 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 10 Mar 2021 | 10,500 | 208,654 | - | 0.6 | 6,300 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 35.28 per share. | 10 Mar 2021 | 5,950 | 198,154 | - | 35.3 | 209,916 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 34.57 per share. | 10 Mar 2021 | 4,550 | 204,104 | - | 34.6 | 157,294 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 10 Feb 2021 | 10,400 | 208,554 | - | 0.6 | 6,240 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 10,400 | 46,194 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 34.76 per share. | 10 Feb 2021 | 6,030 | 199,895 | - | 34.8 | 209,603 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 33.59 per share. | 10 Feb 2021 | 2,629 | 205,925 | - | 33.6 | 88,308 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 35.58 per share. | 10 Feb 2021 | 1,741 | 198,154 | - | 35.6 | 61,945 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 73,500 | 73,500 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2021 | 5,630 | 56,594 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 14 Jan 2021 | 5,630 | 203,784 | - | 0.6 | 3,378 | Common Stock |
| Generation Bio Co | Matthew Stanton | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 31.11 per share. | 14 Jan 2021 | 2,840 | 200,944 | - | 31.1 | 88,352 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges